Cigna appoints Dr. Philip Ozuah to Board of Directors effective June 1, 2023

Cigna Group

Dr. Philip Ozuah appointed independent director on Cigna Board effective June 1, 2023.
Ozuah is President & CEO of Montefiore Medicine, overseeing 13 hospitals and 300 ambulatory sites.
He brings deep expertise in value-based care and population health from 32 years at Montefiore.
Over 60% of Cigna's Board has been refreshed in the past five years to enhance diversity.
Ozuah will serve on the People Resources and Compliance Committees.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Dr. Philip Ozuah

Director

CI · Cigna Group

Effective: 2023-06-01
Filed: May 1, 2023, 7:59 PM ET

On April 26, 2023, the board of directors (the “Board”) of The Cigna Group (the “Company” or “our”) appointed Dr. Philip Ozuah as an independent member of our Board and to the People Resources and Compliance Committees, which appointments are effective June 1, 2023.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Dr. Philip Ozuah was appointed as Director at Cigna Group.

Action: appointed
Role: Director

Exact text from the filing

On April 26, 2023, the board of directors (the “Board”) of The Cigna Group (the “Company” or “our”) appointed Dr. Philip Ozuah as an independent member of our Board and to the People Resources and Compliance Committees, which appointments are effective June 1, 2023.

View on SEC.gov

Cigna Group filing history →

Source: SEC EDGAR

accession 0000950159-23-000157

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.